These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury. Hahn RA, MacDonald BR, Morgan E, Potts BD, Parli CJ, Rinkema LE, Whitesitt CA, Marshall WS. J Pharmacol Exp Ther; 1992 Mar; 260(3):979-89. PubMed ID: 1312172 [Abstract] [Full Text] [Related]
6. Antagonism of leukotriene receptors and administration of a 5-lipoxygenase inhibitor do not affect hypoxic vasoconstriction. Thomas HM, Sourour MS, Lopez D, Foster SH. Lung; 1989 Mar; 167(3):187-98. PubMed ID: 2567790 [Abstract] [Full Text] [Related]
8. Direct and indirect effects of leukotriene D4 on the pulmonary and systemic circulations. Ahmed T, Marchette B, Wanner A, Yerger L. Am Rev Respir Dis; 1985 Apr; 131(4):554-8. PubMed ID: 2986501 [Abstract] [Full Text] [Related]
14. Systemic and regional hemodynamic effects of leukotrienes D4 and E4 in the conscious rat. Eimerl J, Sirén AL, Feuerstein G. Am J Physiol; 1986 Oct; 251(4 Pt 2):H700-9. PubMed ID: 3021000 [Abstract] [Full Text] [Related]
15. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock. Cook JA, Li EJ, Spicer KM, Wise WC, Halushka PV. Circ Shock; 1990 Nov; 32(3):209-18. PubMed ID: 2175680 [Abstract] [Full Text] [Related]